You have full access to this article via your institution. The FDA has approved Fondazione Telethon ETS’s etuvetidigene autotemcel (Waskyra) for Wiskott–Aldrich syndrome (WAS). Etuvetidigene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback